Health issues can lead to financial crises. UCPMP tackles unethical practices like Dolo-650 controversy, CBDT accusations. Requires support from pharma associations, strict laws, and industry accountability.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.